IBOPRES

Ibogaine Dr.Moshe Zer -Zion Beer-Yaacov Mental Health Center Israel

Ibogaine ,[object Object],[object Object],[object Object],[object Object]

Forms in Current Use ,[object Object]

Forms in Current Use ,[object Object],[object Object]

Brief Historical Time Line ,[object Object],[object Object],[object Object],[object Object]

Brief Historical Time Line ,[object Object],[object Object],[object Object]

Brief Historical Time Line ,[object Object]

Mechanisms of Action ,[object Object],[object Object],[object Object]

Glutamate ,[object Object],[object Object]

Glutamate ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Glutamate ,[object Object],[object Object],[object Object],[object Object]

Opioid ,[object Object],[object Object],[object Object],[object Object]

Serotonin ,[object Object],[object Object],[object Object]

Dopamine ,[object Object],[object Object],[object Object]

Acetylcholine ,[object Object],[object Object],[object Object]

Sigma Receptors ,[object Object],[object Object],[object Object],[object Object]

Sigma Receptors ,[object Object],[object Object],[object Object]

Glial cell line-derived neurotrophic factor (GDNF) ,[object Object],[object Object],[object Object]

Summary of Mechanisms of Action of Ibogaine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Possible effects on Neuroadaptations Related to Drug Sensitization or Tolerance ,[object Object],[object Object],[object Object]

Evidence of efficacy in Animal models ,[object Object],[object Object],[object Object],[object Object],[object Object]

Drug Self-Administration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Acute Opioid withdrawal ,[object Object],[object Object]

Conditioned place preference ,[object Object]

Locomotor activity ,[object Object]

Dopamine efflux . ,[object Object],[object Object],[object Object]

Evidence of efficacy and subjective effects in humans ,[object Object],[object Object],[object Object],[object Object]

Acute Opioid withdrawal ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Long-TermOutcomes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Subjective Effects ,[object Object],[object Object],[object Object],[object Object]

Subjective Effects ,[object Object],[object Object],[object Object],[object Object],[object Object]

Subjective Effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pharmacokinetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pharmacokinetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Each form has ,[object Object],[object Object],[object Object]

Dose and Dose Regimen ,[object Object],[object Object],[object Object],[object Object],[object Object]

Dose and Dose Regimen ,[object Object],[object Object],[object Object]

Dose and Dose Regimen ,[object Object],[object Object]

Frequent side effects of Ibogaine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Safety ,[object Object],[object Object],[object Object],[object Object],[object Object]

Safety ,[object Object],[object Object],[object Object]

Observations in Humans ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Observations in Humans ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Observations in Humans ,[object Object],[object Object],[object Object],[object Object],[object Object]

Abuse liability ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

IBOPRES

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

En vedette

En vedette (6)

Similaire à IBOPRES

Similaire à IBOPRES (20)

Plus de Sheldon Pelletier

Plus de Sheldon Pelletier (17)

Dernier

Dernier (20)

IBOPRES